Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$118,035,000
+$6,875,611 QoQ
Shares Held
3,050,000
+5.6% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
7.08%
of 13F equity value
Holder Rank
#16
of 321 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. COGT ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
12,000,000 | $224,520,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
3,275,000 | $166,206,250 | |
| 3 | COGT |
Cogent Biosciences, Inc.
This page
|
3,050,000 | $118,035,000 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
2,000,000 | $94,080,000 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
846,786 | $75,177,661 | |
| 6 | ANRO |
Alto Neuroscience, Inc.
|
2,723,196 | $71,865,142 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,250,000 | $70,335,000 | |
| 8 | EYPT |
EyePoint, Inc.
|
4,600,000 | $65,780,000 |
All Filings in COGT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,035,000 | 3,050,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $111,159,389 | 2,888,007 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,031,934 | 2,196,845 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $104,110,000 | 7,250,000 | Shares | Sole | 2025-11-14 | |
| 2025-07-07 | $59,915,361 | 6,408,060 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $16,594,157 | 2,311,164 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $53,267,967 | 8,892,816 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $53,676,706 | 6,881,629 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,431,244 | 7,539,930 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $82,091,340 | 9,738,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,176,000 | 6,425,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,728,232 | 5,566,026 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $54,268,753 | 5,566,026 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $65,901,747 | 5,566,026 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $51,494,422 | 4,772,421 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $49,938,506 | 4,319,940 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $64,453,504 | 4,319,940 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,601,266 | 4,944,708 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,220,752 | 3,500,768 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,573,682 | 2,281,315 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,084,217 | 1,912,511 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,091,090 | 1,367,582 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $11,143,532 | 1,269,195 | Shares | Sole | 2021-10-14 | |
| 2020-12-31 | $8,535,080 | 760,025 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||